Michelle Mitchell: Great article from Amy Warnock on Cancer Waiting times

Michelle Mitchell shared on LinkedIn:

“The percentage of cancer patients facing long waits in England has almost tripled since 2017. Throughout the 2000s NHS waits were massively reduced through investment, reform and decisive leadership – and the same can be achieved again.

The newly elected Labour Government has a huge opportunity to turn things around. A long-term cancer strategy is needed to deliver on their commitment to bring cancer waiting times down, by providing our NHS with the equipment and staff it desperately needs to diagnose and treat patients on time.

Great article from Cancer Research UK (CRUK)’s Amy Warnock on who the ‘long waiters’ are, the reasons behind delayed treatment, and what can be done.”

Source: Michelle Mitchell/LinkedIn

Michelle Mitchell is the first female chief executive of Cancer Research UK (CRUK), the world’s leading charitable funder of cancer research. In 2021/22 the charity had an income of £668m, spent £443m on cancer research and had approximately 4,000 staff and over 30,000 volunteers.

Before joining Cancer Research UK, Michelle was CEO of the MS Society for five years and a founding member of the Progressive MS Alliance: a global scientific and research joint venture and launched the STOP MS £100m appeal.

Prior to that, she was Director General at Age UK, the UK’s largest older people’s charity where she worked for nearly a decade and was at the forefront of national debates on health, care and welfare. Mitchell was appointed Order of the British Empire (OBE) in the 2016 New Year Honours for services to Older People and the Voluntary Sector. She was named by Cranfield University as one of the 100 Women to Watch in 2018.